retatrutide deutschland Online Triple hormone receptor agonist retatrutide

Weintraub: These new medications are game-changers, but theyre not one-size-fits-all

This study examined whether people who started a glucagon-like peptide-1 receptor agonist (GLP-1) like Zepbound or Ozempic were less likely to develop a substance use disorder, and whether people who already had a substance use disorder had fewer serious complications

DOI: 10.1038/s41366-025-01859-6 Joy B, Ramsamooj A, Ibrahim S, et al

Plus, it has anti-inflammatory benefits, which may help with overall metabolic balance

Most side effects are mild and temporary, especially when the procedure is performed by experienced healthcare professionals

J.PooleC